RecruitingNCT07388628

ARTICE® Real Data Collection & Observational Trial, Phase 4 Study

ARTISTRY - ARTICE® Therapy Registry Study

Sponsor

Artcline GmbH

Enrollment

200 participants

Start Date

Sep 25, 2025

Study Type

OBSERVATIONAL

Conditions

Sepsis Septic Shock Immunoparalysis in Septic Shock

Summary

The objectives of this registry study are to: 1. Record real-life data related to the use of the ARTICE® therapy in sepsis subjects. 2. Further evaluate ARTICE® treatment efficacy. 3. Identify potential sub-groups, assess their risk-benefit- and safety profile. 4. Changes in SOFA score D0 to SOFA Score D7.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with immunoparalysis in septic shock, sepsis, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(2)

Klinikum Magdeburg, Klinik für Intensiv- und Rettungsmedizin

Magdeburg, Germany

Johannes Wesling Klinikum, Universitätsklinik für Anästhesiologie, Intensiv & Notfallmedizin

Minden, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07388628

Related Trials

A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

NCT0721570272 locations

Peripheral Perfusion Index Trajectory to Predict 28-Day Mortality in Patients With Sepsis in the Intensive Care Unit

NCT077403042 locations

Microbiome and Enteric Signatures in Sepsis-associated Hepatorenal Injury

NCT077351821 location

PyroEVs/PLIN3 Mediate Lipid Droplet-Mitochondrial Coupling in Sepsis Endothelial Injury

NCT077272651 location

SEPSIS EARLY WARNING: NEWS2 VS MACHINE LEARNING

NCT077344801 location